References
- 1. Wood GC, Jonap BL, Maish III GO, Magnotti LJ, Swanson JM, Boucher BA, et al. Treatment of Achromobacter Ventilator-Associated Pneumonia in Critically Ill Trauma Patients. Ann Pharmacother. 2018;52:120-5. DOI: 10.1177/106002801773083810.1177/106002801773083828906137
- 2. Re MF, Rocchetti NS, Settecase CJ, Bagilet DH. Diagnostic value of procalcitonin in ventilator-associated pneumonia. Med Clin. 2019;152:216-21. DOI: 10.1016/j.medcle.2019.01.01110.1016/j.medcle.2019.01.011
- 3. Li C, Zhu L, Gong X, Xu Z, Liu Y, Zhang M, et al. Soluble triggering receptor expressed on myeloid cells 1 as a useful biomarker for diagnosing ventilator associated pneumonia after congenital cardiac surgery in children. Exp Ther Med. 2019;17:147-52. DOI: 10.3892/etm.2018.690510.3892/etm.2018.6905630741330651775
- 4. Iosifidis E, Pitsava G, Roilides E. Ventilator-associated pneumonia in neonates and children: a systematic analysis of diagnostic methods and prevention. Future Microbiol. 2018;13:1431-46. DOI: 10.2217/fmb-2018-010810.2217/fmb-2018-010830256161
- 5. Fu CM, Chang CH, Fan PC, Tsai MH, Lin SM, Kao KC, et al. Prognosis of critically ill cirrhotic versus non-cirrhotic patients: a comprehensive score-matched study. BMC Anesthesiol. 2014;14:123. DOI: 10.1186/1471-2253-14-12310.1186/1471-2253-14-123428957725580088
- 6. Intensive Care Medicine Branch of Chinese Medical Association. [Guidelines for the Diagnosis, Prevention and Treatment of Ventilator-Associated Pneumonia (2013)]. Chin J Intern Med. 2013;52:524-43.
- 7. Gaudet A, Martin-Loeches I, Povoa P, Rodriguez A, Salluh J, Duhamel A, et al. Accuracy of the clinical pulmonary infection score to differentiate ventilator-associated tracheobronchitis from ventilator-associated pneumonia. Ann Intens Care. 2020;10:101. DOI: 10.1186/s13613-020-00721-410.1186/s13613-020-00721-4739688732748025
- 8. Bos LD, Kalil AC. Changes in lung microbiome do not explain the development of ventilator-associated pneumonia. Intens Care Med. 2019;45:1133-5. DOI: 10.1007/s00134-019-05691-110.1007/s00134-019-05691-131317208
- 9. De Neef M, Bakker L, Dijkstra S, Raymakers-Janssen P, Vileito A, Ista E. Effectiveness of a Ventilator Care Bundle to Prevent Ventilator-Associated Pneumonia at the PICU: A Systematic Review and Meta-Analysis. Pediatr Crit Care Med. 2019;20:474-80. DOI: 10.1097/PCC.000000000000186210.1097/PCC.000000000000186231058785
- 10. Wang Q, Hou D, Wang J, An K, Han C, Wang C. Procalcitonin-guided antibiotic discontinuation in ventilator-associated pneumonia: a prospective observational study. Infect Drug Resist. 2019;12:815-24. DOI: 10.2147/IDR.S19085910.2147/IDR.S190859649787131114263
- 11. Beye F, Vigneron C, Dargent A, Prin S, Andreu P, Large A, et al. Adhering to the procalcitonin algorithm allows antibiotic therapy to be shortened in patients with ventilator-associated pneumonia. J Crit Care. 2019;53:125-31. DOI: 10.1016/j.jcrc.2019.05.02210.1016/j.jcrc.2019.05.02231228763
- 12. Wongsurakiat P, Tulatamakit S. Clinical pulmonary infection score and a spot serum procalcitonin level to guide discontinuation of antibiotics in ventilator-associated pneumonia: a study in a single institution with high prevalence of nonfermentative gram-negative bacilli infection. Ther Adv Respir Dis. 2018;12:1-13. DOI: 10.1177/175346661876013410.1177/1753466618760134594166529506460
- 13. Coelho L, Rabello L, Salluh J, Martin-Loeches I, Rodriguez A, Nseir S, et al. C-reactive protein and procalcitonin profile in ventilator-associated lower respiratory infections. J Crit Care. 2018;48:385-9. DOI: 10.1016/j.jcrc.2018.09.03610.1016/j.jcrc.2018.09.03630308469
- 14. Edel Y, Kliminski V, Pokroy-Shapira E, Oren S, Lazar AD, Basson YP, et al. Elevated plasma level of soluble triggering receptor expressed on myeloid cells-1 is associated with inflammation activity and is a potential biomarker of thrombosis in primary antiphospholipid syndrome. Arthritis Res Ther. 2019;21:1-10. DOI: 10.1186/s13075-018-1779-510.1186/s13075-018-1779-5632366930616644
- 15. Moralesortiz J, Rondina MT, Brown SM, Grissom C, Washington AV. High Levels of Soluble Triggering Receptor Expressed on Myeloid Cells-Like Transcript (TLT)-1 Are Associated with Acute Respiratory Distress Syndrome. Clin Appl Thromb Hemost. 2018;24:1122-7. DOI: 10.1177/107602961877414910.1177/1076029618774149621975729758998
- 16. Van Oort PM, Bos LD, Povoa P, Ramirez P, Torres A, Artigas A, et al. Soluble urokinase plasminogen activator receptor for the prediction of ventilator-associated pneumonia. ERJ Open Res. 2019;5(1):00212-2018. DOI: 10.1183/23120541.00212-201810.1183/23120541.00212-2018643175230918897
- 17. Chen C, Yan M, Hu C, Lv X, Zhang H, Chen S. Diagnostic efficacy of serum procalcitonin, C-reactive protein concentration and clinical pulmonary infection score in Ventilator-Associated Pneumonia. Med Sci. 2018;34:26-32. DOI: 10.1051/medsci/201834f10510.1051/medsci/201834f10530403171
- 18. Elgazzar AE, Hosny H, Elkhateeb TH. Procalcitonin and clinical pulmonary infection score as predictors of stroke-associated pneumonia: a prospective observational single-center study. Egypt J Chest Dis Tuberc. 2017;2090:9950.